Stayble Is A Clinical Stage Pharmaceutical Company Developing The Injectable Treatment Sta363 For Disc Herniathe Treatment Is Aimed At Patients Whose Back Pain Persists After Physiotherapy And Painkillersthe Injection Is Given Onceand The Effect Is Expected To Remain Throughout The Entirety Of The Patient S Life And To Require Minimal Rehabilitationthe Company S Focus Is Set Upon The Continued Clinical Development Of The Ongoing Clinical Phase 1B Studystayble S Vision Is To Develop Sta363 As A New Standard Treatment For Patients Suffering From Pain Caused By Disc Hernia
No conferences found for this company.
| Company Name | Stayble Therapeutics Ab |
| Country |
Sweden
|
| Address | N/A |
| Telephone | N/A |
| N/A |
